Reviewing Kewaunee Scientific (NASDAQ:KEQU) & CardioGenics (OTCMKTS:CGNH)

Kewaunee Scientific (NASDAQ:KEQU) and CardioGenics (OTCMKTS:CGNH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Profitability

This table compares Kewaunee Scientific and CardioGenics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.41%	14.10%	5.55%
CardioGenics	N/A	N/A	N/A

Volatility & Risk

Kewaunee Scientific has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, CardioGenics has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Kewaunee Scientific and CardioGenics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0	1	0	0	2.00
CardioGenics	0	0	0	0	0.00

Given CardioGenics’ higher possible upside, analysts clearly believe CardioGenics is more favorable than Kewaunee Scientific.

Valuation & Earnings

This table compares Kewaunee Scientific and CardioGenics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282.00 million	0.37	$9.62 million	$3.22	11.30
CardioGenics	N/A	N/A	N/A	N/A	N/A

Kewaunee Scientific has higher revenue and earnings than CardioGenics.

Institutional & Insider Ownership

32.7% of Kewaunee Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by insiders. Comparatively, 41.4% of CardioGenics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Kewaunee Scientific beats CardioGenics on 7 of the 9 factors compared between the two stocks.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

About CardioGenics

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.